Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)

We analyzed data for women who received fondaparinux for ≥7 days during pregnancy. The study retrospectively included women who received fondaparinux pre-, peri- and/or postpartum for ≥7 days for prophylaxis/venous thromboembolism (VTE) treatment at German specialist centers (2004-2010). Data on pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Appl Thromb Hemost
Autores principales: Dempfle, Carl-Erik, Koscielny, Jürgen, Lindhoff-Last, Edelgard, Linnemann, Birgit, Bux-Gewehr, Irene, Kappert, Günther, Scholz, Ute, Kropff, Stefan, Eberle, Sonja, Bramlage, Peter, Heinken, Andreas
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8114740/
https://ncbi.nlm.nih.gov/pubmed/33942675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/10760296211014575
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares